Dogwood Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-15.7M | $-15.7M | — | $322.9K |
| FY2022 | $-11.5M | $-11.5M | — | $582.7K |
| FY2023 | $-4.9M | $-4.9M | — | $620.0K |
| FY2024 | $-8.8M | $-8.8M | — | $476.0K |
| FY2025 | $-15.6M | $-15.6M | — | $355.6K |